A budget impact model and a cost-utility analysis of reducer device (Neovasc) in patients with refractory angina.

导出 LinkOut

翻译打印收藏纠错

作者： Agostino,Fortunato ^[1] ; Ilaria,Valentini ^[1] ; Filippo,Rumi ^[1] ; Debora,Antonini ^[1] ; Ludovica,Siviero ^[1] ; Eugenio,Di Brino ^[1] ; Michele,Basile ^[1] ; Americo,Cicchetti ^[1]

作者单位： Alta Scuola di Economia e Management dei Sistemi Sanitari (ALTEMS) - Università Cattolica del Sacro Cuore, Roma, Italy. ^[1]

关键词 budget impact coronary sinus cost–utility analysis myocardial ischemia reducer refractory angina

DOI 10.3389/fcvm.2024.1307534

PMID 38562187

发布时间 2024-04-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in cardiovascular medicine

2024年11卷

1307534页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A budget impact model and a cost-utility analysis of reducer device (Neovasc) in patients with refractory angina.

Frontiers in cardiovascular medicine

相似文献

Frontiers in cardiovascular medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A budget impact model and a cost-utility analysis of reducer device (Neovasc) in patients with refractory angina.

Frontiers in cardiovascular medicine

相似文献

Frontiers in cardiovascular medicine

相关期刊

检索历史清除